Clinical Trial Update: Tdap Vaccine in Post-Partum Women [Phase 4]

View source ↗

Summary

A Phase 4 trial reports results for the Tdap vaccine in postpartum women, assessing protection against diphtheria, tetanus, and pertussis. The study is complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Pertussis
• Tetanus

Drugs mentioned

• Tdap vaccine (Diphtheria, tetanus, and pertussis vaccine (Tdap))

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Diphtheria, Pertussis | Phase 4 | Status: COMPLETED | Results posted: 2017-05-05